Is Amgen Stock A Buy As The Biotech Company Deepens Its Cancer Focus?

Is Amgen Stock A Buy As The Biotech Company Deepens Its Cancer Focus?

Amgen stock hit a 2020 high point in July, but faded at the end of the year despite the biotech company's focus on cancer, migraine and coronavirus treatments. Is Amgen stock a buy now?